Back
Catalyst Pharmaceuticals, Inc. Vs. Avalo Therapeutics, Inc. Industry Stock Comparison
Buy
81
CPRX
Catalyst Pharmaceuticals, Inc.
Last Price:
$24.06
Seasonality Move:
14.38%
Sell
43
AVTX
Avalo Therapeutics, Inc.
Last Price:
$18.48
Seasonality Move:
0.84%
Buy
81
Catalyst Pharmaceuticals, Inc. (CPRX)
is a Buy
Is Catalyst Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Catalyst Pharmaceuticals, Inc. [CPRX] share price is $24.35. The Score for CPRX is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
-
CPRX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
43
Avalo Therapeutics, Inc. (AVTX)
is a Sell
Is Avalo Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Avalo Therapeutics, Inc. [AVTX] share price is $18.37. The Score for AVTX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
AVTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals, Inc.'s stock price today?
-
The Catalyst Pharmaceuticals, Inc. share price today is $24.35The current trend is moderately bullish and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
AVTX Stock Price Chart
What is Avalo Therapeutics, Inc.'s stock price today?
-
The Avalo Therapeutics, Inc. share price today is $18.37The current trend is moderately bullish and AVTX is experiencing selling pressure, which indicates risk of future bearish movement.
CPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.5 | Buy |
| Relative Strength Index (14 RSI): | 62.99 | Buy |
| Chaikin Money Flow: | 361542 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.91 - 24.07) | Buy |
| Bollinger Bands (100): | (19.92 - 22.86) | Buy |
AVTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.51 | Buy |
| Relative Strength Index (14 RSI): | 51.28 | Buy |
| Chaikin Money Flow: | -79432 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.43 - 19.31) | Buy |
| Bollinger Bands (100): | (10.48 - 17.8) | Buy |
CPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.12 | Buy |
| 20-day SMA: | 23.53 | Buy |
| 50-day SMA: | 22.55 | Buy |
| 200-day SMA: | 22.2 | Buy |
| 8-day EMA: | 24.1 | Buy |
| 20-day EMA: | 23.64 | Buy |
| 50-day EMA: | 22.45 | Buy |
| 200-day EMA: | 14.22 | Buy |
AVTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.72 | Sell |
| 20-day SMA: | 18.46 | Sell |
| 50-day SMA: | 17.39 | Buy |
| 200-day SMA: | 9.79 | Buy |
| 8-day EMA: | 18.74 | Sell |
| 20-day EMA: | 18.41 | Sell |
| 50-day EMA: | 16.99 | Buy |
| 200-day EMA: | 14.12 | Buy |
Catalyst Pharmaceuticals, Inc. Earnings Growth & CPRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.08 per share.
Avalo Therapeutics, Inc. Earnings Growth & AVTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $19.59 per share, and an increase next year of $2.12 per share.
Catalyst Pharmaceuticals, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avalo Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||